PUBLISHER: Grand View Research | PRODUCT CODE: 1405885
PUBLISHER: Grand View Research | PRODUCT CODE: 1405885
The global vaginal rejuvenation market size is expected to reach USD 14.34 billion by 2030, registering a CAGR of 22.07% from 2024 to 2030, according to a new report by Grand View Research, Inc. The Growing popularity of vaginal rejuvenation surgery due to the rising number of treatments offered, increasing demand for the surgery, a growing number of research studies, and associated controversies are propelling the market.
In addition, the growing adoption of non-invasive procedures, such as treatment with the help of laser and radiofrequency technologies is market. The launch of fractional carbon dioxide (CO2) laser has gained impressive popularity with promising results. It has significantly improved the lives of vulvovaginal atrophy (VVA) patients. This can be attributed to its non-invasive nature with less or no downtime and better results.
However, the social stigma associated with gynecological treatments and stringent regulations for energy-based gynecological treatments is hampering the market. The food and Drug Administration (FDA) has not approved any energy-based devices for the associated therapy. These devices have not yet established safety and effectiveness in conditions, such as menopause, incontinence, or intercourse.
The onset of COVID-19 affected the global aesthetic market with surgical cosmetic treatments witnessing a significant setback. The majority of the non-essential cosmetic procedures like vaginal rejuvenation were completely halted during the first and second quarters of 2020, however many dermatology and surgical centers have witnessed perpetual ease in reopening their services by the end of 2020 might help recover the market during the forecast period.